Legend Biotech USA Annual Revenue, Competitors, Number of Employees and Funding
Estimated Revenue & Financials
- Legend Biotech USA's estimated annual revenue is currently $29.1M per year.
- Legend Biotech USA's estimated revenue per employee is $155,000
- Legend Biotech USA has 188 Employees.
- Legend Biotech USA grew their employee count by 132% last year.
- Legend Biotech USA currently has 22 job openings.
Legend Biotech USA Competitors
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding|
What Is Legend Biotech USA?
Legend Biotech Corporation is an emerging company focusing on the development of the best-in-class immunotherapy technology for cancer cure. Teamed up with outstanding immunologists and molecular biologists, Legend has generated a strong pipeline of Chimeric Antigen Receptor(CAR) product candidates to treat a wide variety of liquid and solid tumors. Our ambition to succeed in the CARs field has been substantially fulfilled by the latest clinical trial results that we have achieved a great clinical success in treating multiple myeloma, a previously incurable blood cancer. By applying one of our proprietary CAR-T technology, we have reached a promising result in the clinical research for the enrolled patient group bearing refractory and relapsed multiple myeloma. Legend Biotech Corporation is founded on the vision that the previous incurable previousincurable cancer will be safely and effectively treated with fine-tuning products generated on our innovative technology platform. We take our mission very seriously and intend to bring more hopes to desperate patients all over the world.keywords:N/A
Number of Employees
Employee Growth %
|Jerry Zhou||Associate Director of Finance||Email Available|
|Rong Zhou||Director, Regulatory Affairs Cmc, Biologics/car-t||Email Available|
|Yuan Xu||CEO||Email Available|
|Grisel Pierrez||Director of External Quality||Email Available|
|Raghu Tadagavadi||Associate Director||Email Available|
|Steve Gavel||Vice President, Cell Therapy Commercial Development Lead||Email Available|
|Bryan Utter||Director of Material Sciences||Email Available|
|Liz Gosen||SVP, Technical Operations||Email Available|
|Minal Patel||Quality Control Manager||Email Available|
|Mike Hirschmann||Executive Director Commecial Development|
Legend Biotech USA News
... Sorrento Therapeutics (US), Legend Biotech (US), Mustang Bio (US), ... The US is expected to hold the largest share of the global CAR T cell ...
Micro-cap biotech Aridis Pharmaceuticals $ARDS got hammered this ... drug status by US and EU regulators for its experimental drug, elafibranor, ... pit Immunotech against Legend Biotech, a J&J-partnered player owned by ...
In 2017, Janssen entered into a global collaboration and licence agreement with Legend Biotech USA and Legend Biotech Ireland to develop, ...